Ft Lauderdale-based Mako Surgical filed for a 5.1 million share public offering, with a price target of $14-16/share. Mako is led by Maurice Ferre and has a revolutionary approach to knee restoration — utilizing robot guidance for more precise operations, enabling quicker recovery and, ultimately, better outcomes.
I really liked Maurice and his company when we first saw it, but we didn’t pull the trigger alongside Tony Natale (formerly MDS, now at Prism). Mako proceeded to raise $50M of private equity and a fast path to the big show. Congrats to Maurice, Tony and the whole Mako team!